New Real-Time PCR System Offers Integrated qPCR and Genotyping Applications

A new high productivity, real-time PCR system that integrates a variety of quantitative PCR (qPCR) and genotyping applications will be available in June 2010.

The new system, the Applied Biosystems ViiA Real-Time PCR, is a product of Life Sciences Corporation (Carlsbad, CA, USA), a global biotechnology tools company that describes itself as being "dedicated to improving the human condition”.

The ViiA Real-Time PCR System incorporates a software package that melds standard real-time PCR applications such as nucleic acid quantification, detection of single nucleotide polymorphisms (SNPs), and copy number variation detection with others that include high-resolution melting, protein analysis with proximity ligation technology, and gene expression analysis performed directly from cultured cells without RNA purification. All applications are integrated and easily accessible from a touch screen so that investigators can operate the system without a separate computer and monitor runs from remote locations.

"In the past decade, quantitative real-time PCR has become a cornerstone technology for the life science researcher, allowing scientists around the world to identify molecular markers for disease and precisely measure how changes in activity at the genome level translate to significant molecular outcomes in living systems,” said Peter Dansky, president of molecular biology systems for Life Technologies. "By integrating a broad portfolio of real-time PCR applications on a single high-performance platform, the ViiA 7 Real-Time PCR System will vastly increase the productivity of researchers and inspire them to develop novel workflows that lead to an even greater understanding of the molecular basis of health and disease.”

Related Links:
Life Sciences Corporation